Protega Pharms

JUN 18, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Roxybond (REMS)

U.S. Food and Drug Administration

FDA supplemental approval of REMS requirements for Roxybond (oxycodone hydrochloride); this is a regulatory action record without clinical trial data.